Biomea Fusion Analyst Price Targets

Wall Street analyst price targets and consensus rating for Biomea Fusion (BMEA).

Price Target Range — 12 Quarters

Analyst Consensus — 13 Analysts

1S.Buy

11Buy

1Hold

Consensus RatingBuy# Analysts13Avg. Consensus PT$17Upside to Avg. PT+2713.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 14, 2026	Citizens	Jonathan Wolleben	Maintained	Market Outperform	$7
Oct 14, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Oct 7, 2026	Brookline Capital	Kumaraguru Raja	Initiate	Buy	$10
May 5, 2026	Citizens	Jonathan Wolleben	Initiate	Market Outperform	$9
Apr 28, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$12
Apr 8, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$12
Mar 27, 2026	Citigroup	Yigal Nochomovitz	PT Raise	Buy	$6→$7
Mar 25, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$12
Jan 13, 2026	D. Boral Capital	Jason Kolbert	Maintained	Buy	$12
Nov 10, 2025	Citigroup	Yigal Nochomovitz	PT Cut	Buy	$7→$6
Nov 5, 2025	D. Boral Capital	Jason Kolbert	PT Cut	Buy	$16→$12
Oct 27, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Oct 7, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Oct 3, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Aug 28, 2025	Jefferies	Roger Song	Initiate	Buy	$5
Aug 11, 2025	Citigroup	Yigal Nochomovitz	PT Cut	Buy	$9→$7
Aug 6, 2025	Scotiabank	George Farmer	PT Cut	Sector Outperform	$30→$10
Aug 6, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Jul 21, 2025	D. Boral Capital	Jason Kolbert	Maintained	Buy	$16
Jul 16, 2025	Citigroup	Yigal Nochomovitz	PT Cut	Buy	$22→$9

Analyst Ratings News

PRO
Citizens Reiterates Market Outperform on Biomea Fusion, Maintains $7 Price Target

Citizens analyst Jonathan Wolleben reiterates Biomea Fusion (NASDAQ:BMEA) with a Market Outperform and maintains $7 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $4 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Biomea Fusion (NASDAQ:BMEA) with a Buy and maintains $4 price target.

Benzinga Newsdesk

PRO
Brookline Capital Initiates Coverage On Biomea Fusion with Buy Rating, Announces Price Target of $10

Brookline Capital analyst Kumaraguru Raja initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Buy rating and announces Price Target of $10.

Benzinga Newsdesk

This Applied Materials Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed outlook on top names. See analyst ratings page for all changes. Citations for AMAT, BMEA, ACRS, KALU, SION.

Avi Kapoor

PRO
Citizens Initiates Coverage On Biomea Fusion with Market Outperform Rating, Announces Price Target of $9

Citizens analyst Jonathan Wolleben initiates coverage on Biomea Fusion (NASDAQ:BMEA) with a Market Outperform rating and announces Price Target of $9.

Benzinga Newsdesk

PRO
Citigroup Maintains Buy on Biomea Fusion, Raises Price Target to $7

Citigroup analyst Yigal Nochomovitz maintains Biomea Fusion (NASDAQ:BMEA) with a Buy and raises the price target from $6 to $7.

Benzinga Newsdesk

Biomea Fusion Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Biomea Fusion Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Citizens Reiterates Market Outperform on Biomea Fusion, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $4 Price Target

PRO
Brookline Capital Initiates Coverage On Biomea Fusion with Buy Rating, Announces Price Target of $10

This Applied Materials Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

PRO
Citizens Initiates Coverage On Biomea Fusion with Market Outperform Rating, Announces Price Target of $9

PRO
Citigroup Maintains Buy on Biomea Fusion, Raises Price Target to $7

People Also Watch

People Also Watch

Biomea Fusion Inc

ニュース

パートナーシップ

ベンジンガ・グローバル

Biomea Fusion Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCitizens Reiterates Market Outperform on Biomea Fusion, Maintains $7 Price Target

PROHC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $4 Price Target

PROBrookline Capital Initiates Coverage On Biomea Fusion with Buy Rating, Announces Price Target of $10

This Applied Materials Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

PROCitizens Initiates Coverage On Biomea Fusion with Market Outperform Rating, Announces Price Target of $9

PROCitigroup Maintains Buy on Biomea Fusion, Raises Price Target to $7

People Also Watch

People Also Watch

PRO
Citizens Reiterates Market Outperform on Biomea Fusion, Maintains $7 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Biomea Fusion, Maintains $4 Price Target

PRO
Brookline Capital Initiates Coverage On Biomea Fusion with Buy Rating, Announces Price Target of $10

PRO
Citizens Initiates Coverage On Biomea Fusion with Market Outperform Rating, Announces Price Target of $9

PRO
Citigroup Maintains Buy on Biomea Fusion, Raises Price Target to $7